Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Wei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9931-5990; OpenAlex author ID A5100318082. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 6

  1. A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer. Co-author DOI 10.1016/j.mtbio.2025.101696↗
  2. A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33284↗
  3. Abnormal expression of lncRNA UCA1 disturbed cell apoptosis through mediating mitochondrial dynamics in PDAC. Co-author DOI 10.4149/neo_2020_200629n671↗
  4. Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis. Co-author DOI 10.3892/ol.2019.10444↗
  5. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Co-author DOI 10.2174/09298673113209990251↗
  6. Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature. Co-author DOI 10.3892/ol.2013.1200↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiguo Li · 1 shared paper, 2025 · strength 0.27
  2. Jiawei Wang · 1 shared paper, 2025 · strength 0.27
  3. Buwei Teng · 1 shared paper, 2021 · strength 0.19
  4. Zhong Wang · 1 shared paper, 2021 · strength 0.19
  5. Kota Nakamura · 1 shared paper, 2021 · strength 0.12
  6. Kenji Nakagawa · 1 shared paper, 2021 · strength 0.12
  7. Satoshi Nishiwada · 1 shared paper, 2021 · strength 0.12
  8. Naoya Ikeda · 1 shared paper, 2021 · strength 0.12
  9. Masayuki Sho · 1 shared paper, 2021 · strength 0.12
  10. Tadataka Takagi · 1 shared paper, 2021 · strength 0.12
  11. Kensuke Yamamura · 1 shared paper, 2021 · strength 0.12
  12. Takahiro Akahori · 1 shared paper, 2021 · strength 0.12
  13. Minako Nagai · 1 shared paper, 2021 · strength 0.12
  14. Ajay Goel · 1 shared paper, 2021 · strength 0.12
  15. Hideo Baba · 1 shared paper, 2021 · strength 0.12
  16. Mengdan Xu · 1 shared paper, 2019 · strength 0.10
  17. Yihang Yuan · 1 shared paper, 2019 · strength 0.10
  18. Daoming Li · 1 shared paper, 2019 · strength 0.10
  19. Mengyao Wu · 1 shared paper, 2019 · strength 0.10
  20. Jian Zhou · 1 shared paper, 2019 · strength 0.10
  21. Ling Mai · 1 shared paper, 2013 · strength 0.04
  22. Yong Zhang · 1 shared paper, 2013 · strength 0.04
  23. Qingyong Ma · 1 shared paper, 2013 · strength 0.03
  24. Jiangbo Liu · 1 shared paper, 2013 · strength 0.03
  25. Erxi Wu · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.